PL2477992T3 - Proces przygotowania Darunawiru i jego amorficznych postaci - Google Patents

Proces przygotowania Darunawiru i jego amorficznych postaci

Info

Publication number
PL2477992T3
PL2477992T3 PL10795061T PL10795061T PL2477992T3 PL 2477992 T3 PL2477992 T3 PL 2477992T3 PL 10795061 T PL10795061 T PL 10795061T PL 10795061 T PL10795061 T PL 10795061T PL 2477992 T3 PL2477992 T3 PL 2477992T3
Authority
PL
Poland
Prior art keywords
darunavir
processes
preparation
amorphous form
amorphous
Prior art date
Application number
PL10795061T
Other languages
English (en)
Inventor
Siva Rama Prasad Vellanki
Arabinda Sahu
Aravind Kumar Katukuri
Vikram Vanama
Satishbabu Kothari
Venkata Suryanarayana Ponnekanti
Debashish Datta
Original Assignee
Mylan Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mylan Laboratories Limited filed Critical Mylan Laboratories Limited
Publication of PL2477992T3 publication Critical patent/PL2477992T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL10795061T 2009-09-17 2010-09-16 Proces przygotowania Darunawiru i jego amorficznych postaci PL2477992T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN2257CH2009 2009-09-17
IN54CH2010 2010-01-08
IN939CH2010 2010-04-05
EP10795061.0A EP2477992B1 (en) 2009-09-17 2010-09-16 Processes for the preparation of darunavir and the amorphous form thereof

Publications (1)

Publication Number Publication Date
PL2477992T3 true PL2477992T3 (pl) 2017-07-31

Family

ID=43501151

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10795061T PL2477992T3 (pl) 2009-09-17 2010-09-16 Proces przygotowania Darunawiru i jego amorficznych postaci

Country Status (10)

Country Link
US (1) US8703980B2 (pl)
EP (1) EP2477992B1 (pl)
CA (1) CA2776807C (pl)
DK (1) DK2477992T3 (pl)
ES (1) ES2619562T3 (pl)
HR (1) HRP20170392T1 (pl)
PL (1) PL2477992T3 (pl)
PT (1) PT2477992T (pl)
SI (1) SI2477992T1 (pl)
WO (1) WO2011048604A2 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8921415B2 (en) 2009-01-29 2014-12-30 Mapi Pharma Ltd. Polymorphs of darunavir
WO2010086844A1 (en) * 2009-01-29 2010-08-05 Mapi Pharma Hk Limited Polymorphs of darunavir
BR112012009956A2 (pt) * 2009-10-30 2015-09-29 Lupin Ltd um novo processo para a preparação de darunavir e etanolato darunavir de tamanho de partícula.
WO2011083287A2 (en) * 2010-01-05 2011-07-14 Cipla Limited Darunavir polymorph and process for preparation thereof
PL2528923T3 (pl) 2010-01-28 2015-01-30 Mapi Pharma Ltd Sposób wytwarzania darunawiru i pochodnych darunawiru
WO2012107889A1 (en) * 2011-02-10 2012-08-16 Ranbaxy Laboratories Limited Process for the preparation of amorphous darunavir
PL2729130T3 (pl) * 2011-07-07 2018-02-28 Janssen Sciences Ireland Uc Preparaty kombinowane darunawiru
CN103841962B (zh) 2011-07-07 2016-08-17 爱尔兰詹森科学公司 地瑞纳韦配制品
WO2013011485A1 (en) 2011-07-20 2013-01-24 Ranbaxy Laboratories Limited Process for the preparation of sulfonamides useful as retroviral protease inhibitors
US9216990B2 (en) * 2011-12-05 2015-12-22 Mylan Labs Limited Crystalline Darunavir
WO2013189049A1 (zh) * 2012-06-20 2013-12-27 上海迪赛诺药业有限公司 制备达芦那韦无定形物的方法
CN103509031B (zh) * 2012-06-20 2016-04-27 上海迪赛诺药业有限公司 制备达芦那韦无定形物的方法
EP3795572B1 (en) 2012-07-24 2023-11-15 Laurus Labs Limited Darunavir propionate solvate
US20160075643A1 (en) * 2014-09-16 2016-03-17 Zcl Chemicals Limited Novel process to prepare intermediates of hiv-protease inhibitors thereof
CN106854212A (zh) * 2015-12-08 2017-06-16 浙江九洲药业股份有限公司 一种达芦那韦无定型的制备方法
CN107021919A (zh) * 2016-01-29 2017-08-08 上海医药工业研究院 一种阿扎那韦原料药杂质或其盐、其制备方法和应用
CN107235987A (zh) * 2016-03-28 2017-10-10 浙江九洲药业股份有限公司 一种地瑞那韦甲醇溶剂化物及其制备方法和用途
WO2018015929A1 (en) * 2016-07-22 2018-01-25 Granules India Limited A novel process for the preparation of hiv protease inhibitor and intermediates thereof
EP3532478B1 (en) 2016-10-27 2021-05-26 Gilead Sciences, Inc. Crystalline form of darunavir free base
CN108794498A (zh) * 2017-05-03 2018-11-13 江苏瑞科医药科技有限公司 一种达芦那韦无定型的制备方法
CN108822123A (zh) * 2018-09-06 2018-11-16 南通雅本化学有限公司 一种地瑞那韦的制备方法
CN111039951A (zh) * 2019-12-16 2020-04-21 上海雅本化学有限公司 一种地瑞那韦的制备方法
CN114685322B (zh) * 2020-12-30 2023-08-25 上海飞腾医药科技有限公司 一种抗hiv类药物中间体晶体的生长方法和所得晶体及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968942A (en) 1992-08-25 1999-10-19 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
US7700645B2 (en) * 2002-05-16 2010-04-20 Tibotec Pharmaceuticals Ltd. Pseudopolymorphic forms of a HIV protease inhibitor
KR101192859B1 (ko) 2003-12-23 2012-10-19 얀센 알 앤드 디 아일랜드 (3r,3as,6ar)-헥사하이드로푸로〔2,3-b〕푸란-3-일(1s,2r)-3-〔〔(4-아미노페닐)설포닐〕(이소부틸)아미노〕-1-벤질-2-하이드록시프로필카바메이트의 제조방법
US20080014280A1 (en) * 2006-07-17 2008-01-17 Glenmark Pharmaceuticals Limited Amorphous pregabalin and process for the preparation thereof
US20080014263A1 (en) * 2006-07-17 2008-01-17 Glenmark Pharmaceuticals Limited Amorphous eprosartan mesylate and process for the preparation thereof
WO2010086844A1 (en) 2009-01-29 2010-08-05 Mapi Pharma Hk Limited Polymorphs of darunavir
WO2011017395A1 (en) * 2009-08-04 2011-02-10 Glaxosmithkline Llc Chemical compounds

Also Published As

Publication number Publication date
DK2477992T3 (en) 2017-03-27
EP2477992B1 (en) 2016-12-14
WO2011048604A3 (en) 2011-09-09
CA2776807C (en) 2018-10-16
SI2477992T1 (sl) 2017-05-31
US20120251826A1 (en) 2012-10-04
CA2776807A1 (en) 2011-04-28
HRP20170392T1 (hr) 2017-06-02
PT2477992T (pt) 2017-03-20
EP2477992A2 (en) 2012-07-25
WO2011048604A2 (en) 2011-04-28
US8703980B2 (en) 2014-04-22
ES2619562T3 (es) 2017-06-26

Similar Documents

Publication Publication Date Title
SI2477992T1 (sl) Postopki za pripravo darunavirja in njega amorfne oblike
ZA201202504B (en) Process for the preparation of calcobutrol
PL2519100T3 (pl) Związki pośrednie i sposoby wytwarzania tapentadolu i pokrewnych związków
ZA201204365B (en) Darunavir polymorph and process for preparation thereof
EP2411465A4 (en) PROCESS FOR PREPARING A HETEROPHASIC COPOLYMER AND USES THEREOF
PL2632889T3 (pl) Związki pośrednie i sposób wytwarzania fingolimodu
SI2387566T1 (sl) Postopek za pripravo rosuvastatina
PL390042A1 (pl) Sposób wytwarzania kwasu chlebowego
EP2513116A4 (en) POLYMORPH OF DARUNAVIR
IL220477A (en) A process for making Darunavir and intermediates of Daronavir
PL388931A1 (pl) Sposób otrzymywania fluorokarbofunkcyjnych silseskwioksanów
IL216650A0 (en) Process for the preparation and purification of etravirine and intermediates thereof
PT2655363T (pt) Formas cristalinas e processos para a sua preparação
SI2430078T1 (sl) Postopek za pripravo sevelamerja
PL389013A1 (pl) Nowe winylo-alkinylopodstawione związki germanu oraz sposób otrzymywania winylo-alkinylopodstawionych związków germanu
EP2467375A4 (en) FORMS OF DEXLANDSOPRAZOLE AND METHOD OF MANUFACTURING THEREOF
GB201301307D0 (en) Crystalline form of prulifloxacin and processes for its preparation
PL2462154T3 (pl) Nowa krystaliczna postać CDB-4124 i sposób jej wytwarzania
EG27000A (en) Process for the preparation of ibodutant (MEN15596) and related intermediates
SI2387557T1 (sl) Postopek za pripravo N-(5-(3-dimetilamino-akriloil)-2-fluorofenil)-N-metil-acetamida
IL217460A0 (en) Novel process for the preparation of 4-aminobut-2-enolides
ZA201108148B (en) Triazine-aryl-bis-indoles and process for preparation thereof
PL389594A1 (pl) Sposób wytwarzania sulfidów fluorohalogenometyloarylowych
PL391702A1 (pl) Sposób otrzymywania 5-hydroksykreatyniny i N-metyloguanidyny
PL389932A1 (pl) Wielofunkcyjna propylenoimina i sposób wytwarzania wielofunkcyjnej propylenoiminy